Welcome to LookChem.com Sign In|Join Free
  • or
7-(4-benzylpiperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

93107-14-3

Post Buying Request

93107-14-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

93107-14-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 93107-14-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,1,0 and 7 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 93107-14:
(7*9)+(6*3)+(5*1)+(4*0)+(3*7)+(2*1)+(1*4)=113
113 % 10 = 3
So 93107-14-3 is a valid CAS Registry Number.

93107-14-3Downstream Products

93107-14-3Relevant academic research and scientific papers

Anionic fluoroquinolones as antibacterials against biofilm-producing Pseudomonas aeruginosa

Long, Timothy E.,Keding, Lexie C.,Lewis, Demetria D.,Anstead, Michael I.,Withers, T. Ryan,Yu, Hongwei D.

, p. 1305 - 1309 (2016)

Pseudomonas aeruginosa is a common biofilm-forming bacterial pathogen implicated in diseases of the lungs. The extracellular polymeric substances (EPS) of respiratory Pseudomonas biofilms are largely comprised of anionic molecules such as rhamnolipids and

ANTIBIOTIC RESISTANCE BREAKERS

-

, (2019/01/05)

The invention relates to antibiotic compounds of formula (A1) and pharmaceutically acceptable salts, solvates, tautomers and combinations thereof, wherein X and L are optional linkers and one of RA or R1 comprises Ar1, wherein Ar1 is an antibiotic resistance breaker moiety which comprises an optionally substituted C6-10 aryl, C7-13 aralkyl, C5-10 heteroaryl, C6-13 heteroaralkyl, C5-10 heterocyclyl, C6-13 heterocyclalkyl, C3-10 carbocyclyl, C4-13 carbocyclalkyl, -C(=NR')-NR'R'' or –CH2- CH=CH2 group; wherein after administration of the compound to a bacterial infection this moiety reduces or prevents efflux. The invention also discloses pharmaceutical compositions comprising compounds of formula (A1) and the use of such compounds as medicaments, in particular, to treat bacterial infections, such as drug-resistant bacterial infections.

2-Aminoquinazolin-4(3H)-one as an Organocatalyst for the Synthesis of Tertiary Amines

Thakur, Maheshwar S.,Nayal, Onkar S.,Upadhyay, Rahul,Kumar, Neeraj,Maurya, Sushil K.

supporting information, p. 1359 - 1362 (2018/03/09)

The potential of 2-aminoquinazolin-4(3H)-one as an organocatalyst for the activation of aldehydes via noncovalent interaction for the synthesis of tertiary amines using formic acid as a reducing agent is reported for the first time. The developed protocol demonstrated a dilated substrate scope for aromatic and aliphatic amines with aromatic and aliphatic aldehydes. Furthermore, the current method was also fruitful for the derivatization of ciprofloxacin and its derivative in good to excellent yields.

Pharmacological characterization of 7-(4-(Piperazin-1-yl)) ciprofloxacin derivatives: Antibacterial activity, cellular accumulation, susceptibility to efflux transporters, and intracellular activity

Marquez, Beatrice,Pourcelle, Vincent,Vallet, Coralie M.,Mingeot-Leclercq, Marie-Paule,Tulkens, Paul M.,Marchand-Bruynaert, Jacqueline,Van Bambeke, Francoise

, p. 1290 - 1301 (2014/06/24)

Purpose: To evaluate pharmacological properties (antibacterial activity; accumulation in phagocytic cells; activity against intracellular bacteria; susceptibility to fluoroquinolone efflux transporters) of ciprofloxacin derivatives modified at C-7 of the

Synthesis and biological activity of pyridopyridazin-6-one p38α MAP kinase inhibitors. Part 2

Tynebor, Robert M.,Chen, Meng-Hsin,Natarajan, Swaminathan R.,O'Neill, Edward A.,Thompson, James E.,Fitzgerald, Catherine E.,O'Keefe, Stephen J.,Doherty, James B.

, p. 5971 - 5975 (2012/11/07)

This manuscript concludes the Structure Activity Relationship (SAR) on the pyridazinone scaffold and identifies a compound with subnanomolar p38α activity and 24 h coverage in the rat arthritis efficacy model.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 93107-14-3